Topical Triple Combo
Local DHT blocking plus growth-phase support in one daily scalp formula for classic male pattern loss.
Physician-prescribed finasteride, minoxidil, dutasteride, and custom topical combinations built for specific hair-loss patterns, with async physician oversight from day one.
Experience some degree of androgenetic alopecia driven by follicle miniaturization.
Hair restoration requires consistency and patience across several growth cycles.
Lowest of 6 compounded formulas across men's and women's protocols.
Physician-matched to your specific hair-loss pattern — 3 for men, 3 for women.
Pattern hair loss is usually driven by DHT sensitivity. The goal is to reduce that signal, improve follicle environment, and keep patients on treatment long enough for the biology to work.
It inhibits 5-alpha-reductase, the enzyme that converts testosterone to DHT. That reduction is what slows follicle miniaturization and protects density over time.
Minoxidil improves blood flow and helps keep follicles in the anagen growth phase longer. Early shedding can happen first, but that is often part of the treatment cycle.
Hair restoration is consistency-driven. Your provider reviews your progress at each check-in and helps you tell normal early shedding apart from a protocol that needs adjusting.
Every formula is compounded to a specific hair-loss pattern and reviewed by a licensed physician before it ships — no one-size-fits-all prescription.
Local DHT blocking plus growth-phase support in one daily scalp formula for classic male pattern loss.
A stronger anti-DHT option for patients who need more suppression than finasteride protocols provide.
Direct follicle stimulation plus systemic DHT control for broader coverage in moderate-to-severe loss.
Pricing remains estimated until launch. Provider review determines the final clinical pathway and eligibility.
Join the waitlist now. We’ll notify you the moment enrollment opens and give early members priority access plus locked-in launch pricing.
Hair Restoration is positioned as a coming-soon program. Early access users will be notified first and get launch pricing benefits when the program opens.
Yes. Weeks 2-8 can include increased shedding as weaker hairs cycle out. That does not automatically mean the protocol is failing.
Yes. The provider can account for weight-loss-related shedding and design a combined protocol when clinically appropriate.
No medication is universal. Provider review is required, and finasteride or dutasteride may be inappropriate for some patients depending on sex, pregnancy risk, and health history.